Prognostic impact of high p16/cyclin D1 index in breast cancer

被引：1

作者：

Kim, Gi Jeong ^{[1
,2
]}

Kim, Dong-Hoon ^{[3
]}

Min, Kyueng-Whan ^{[4
]}

Kim, Se Hoon ^{[5
]}

机构：

[1] Gachon Univ, Gil Med Ctr, Dept Pathol, Coll Med, Incheon, South Korea

[2] Yonsei Univ, Dept Med, Grad Sch, Seoul, South Korea

[3] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Pathol, Sch Med, 29 Saemunanro, Seoul 03181, South Korea

[4] Hanyang Univ, Guri Hosp, Dept Pathol, Coll Med, Guri, Gyeonggi Do, South Korea

[5] Yonsei Univ, Severance Hosp, Dept Pathol, Coll Med, Seoul, South Korea

来源：

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 2019年 / 12卷 / 06期

关键词：

Breast cancer; p16; cyclin D1; index; prognosis; CYCLIN D1; RETINOBLASTOMA PROTEIN; P16; PROTEINS; EXPRESSION; OVEREXPRESSION; CARCINOMA; METHYLATION; RB; PROGRESSION; P16(INK4A);

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Proteins p16 and cyclin D1 (CCND1) are known to tightly regulate the G1/S transition during the cell cycle, but their role in breast cancer development and progression is not clear. We investigated 224 cases of breast cancer from the Kangbuk Samsung Medical Center between 2000-2005. Expression levels of p16 and CCND1 were assessed by tissue microarray-based immunohistochemistry. A p16/CCND1 index was divided into low- and high-expression groups using receiver operating characteristic curves. The p16/CCND1 index was significantly different across molecular subtypes and a high p16/CCND1 index was statistically correlated with survival rates. This p16/CCND1 index may be an indicator of poor patient outcome and thus, represents a potential therapeutic target.

引用

页码：2224 / 2232

页数：9

共 50 条

[31] Cyclin D1 expression in invasive breast cancer - Correlations and prognostic value
vanDiest, PJ
Michalides, RJAM
Jannink, I
vanderValk, P
Peterse, HL
deJong, JS
Meijer, CJLM
Baak, JPA
AMERICAN JOURNAL OF PATHOLOGY, 1997, 150 (02): : 705 - 711
[32] DETERMINATION OF THE PROGNOSTIC VALUE OF CYCLIN D1 OVEREXPRESSION IN BREAST-CANCER
MCINTOSH, GG
ANDERSON, JJ
MILTON, I
STEWARD, M
PARR, AH
THOMAS, MD
HENRY, JA
ANGUS, B
LENNARD, TWJ
HORNE, CHW
ONCOGENE, 1995, 11 (05) : 885 - 891
[33] P16 and cyclin D1 (CYD1) as prognostic markers in hypopharyngeal (HSC) and oropharyngeal squamous cell carcinoma (OSC).
Ang, Siok Hoon
Haaland, Benjamin
Thu, Minn Minn Myint
Krishna, Sai Sakktee
Chen, Wallace
Hwang, Siok Gek Jacqueline
Tan, Puay Hoon
Tai, Wai Meng David
Tan, Eng Huat
Lim, Wan-Teck
Ang, Mei-Kim
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[34] Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines
M Sartor
H Steingrimsdottir
F Elamin
J Gäken
S Warnakulasuriya
M Partridge
N Thakker
N W Johnson
M Tavassoli
British Journal of Cancer, 1999, 80 : 79 - 86
[35] Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines
Sartor, M
Steingrimsdottir, H
Elamin, F
Gäken, J
Warnakulasuriya, S
Partridge, M
Thakker, N
Johnson, NW
Tavassoli, M
BRITISH JOURNAL OF CANCER, 1999, 80 (1-2) : 79 - 86
[36] Cyclin D1 in breast cancer pathogenesis
Arnold, A
Papanikolaou, A
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (18) : 4215 - 4224
[37] Cyclin D1 gene amplification and p16 gene deletion in patients with esophageal carcinosarcoma
Suzuki, H
Fujioka, Y
Nagashima, K
DIAGNOSTIC MOLECULAR PATHOLOGY, 1998, 7 (05) : 253 - 259
[38] Expression of retinoblastoma, p16 and cyclin D1 genes in gastric adenocarcinomas and precarcinomatous lesions
Walton, SJ
Feakins, RM
JOURNAL OF PATHOLOGY, 2002, 198 : 32A - 32A
[39] Retinoblastoma and p16 proteins in mammary carcinoma: Their relationship to cyclin D1 and histopathological parameters
Dublin, EA
Patel, NK
Gillett, CE
Smith, P
Peters, G
Barnes, DM
INTERNATIONAL JOURNAL OF CANCER, 1998, 79 (01) : 71 - 75
[40] Evaluation of Gastroenteropancreatic Neuroendocrine Tumors for Ki 67, p16 and Cyclin D1 Expression
Ozyalvacli, Gulzade
Pasaoglu, Esra
Gucin, Zuhal
Behzatoglu, Kemal
Gunver, Feray
Bozkurt, Erol Rustu
ISTANBUL MEDICAL JOURNAL, 2011, 12 (03): : 105 - 112

← 1 2 3 4 5 →